The centre of our activity is patients suffering from haematological diseases. We treat out patients at our Institute’s inpatient department, dedicated to the haemato-oncological diseases or in the clinics located in Bellinzona, Locarno, Lugano or Mendrisio. The Haematology Department consists of various professionals taking care of patients. A team of doctors, biologists, laboratory technicians and secretaries ensure we diagnose and treat our patients optimally.
In order to ensure an optimal diagnostic process, the Haematology Service is in charge of the basic haematology part in all EOLAB laboratories and the Specialist Haematology Laboratory (LEM). The Haematology Service is the only one in Ticino that can provide a comprehensive haematological diagnostic picture by integrating all the techniques currently available in the most advanced centres.
In addition to the laboratory activity, there is also clinical activities treating inpatient haemato-oncological patients. For example, intensive chemotherapy or autologous peripheral stem cell transplantation and outpatient work for specialist investigations and treatment of haematological or haemato-oncological pathologies.
Our service also offers follow-ups to patients after an allogeneic stem cell transplantation (in close collaboration with the University Hospital of Basel). The haematology medical staff are available to the colleagues in other departments (surgery, gynaecology, medicine, etc.) as consultants.
The haematology service's research consists of a clinical and translational part aiming to develop new therapies for malignant haematological diseases. International and national clinical studies are available for most haematological diseases, giving our patients the possibility to receive new and innovative therapies and drugs.
The head of the Haematology service, Prof. Dr. med. Georg Stüssi, is currently Chairman of the Swiss Leukaemia Research Group of the Swiss Cancer Clinical Research Group (SAKK). In addition, the translational research of Prof. Dr. med. Davide Rossi (Institute of Oncology Research, IOR) is involved in the development of new molecules and the treatment of chronic lymphatic leukaemia, which is the most common form of leukaemia in Europe.
In order to make a definitive diagnosis, close cooperation with other bodies such as the Cantonal Institute of Pathology, EOLAB (Department of Laboratory Medicine) and the Transfusion Service is vital. The haematology service collaborates with all other clinics within the EOC. We also have many national collaborations with universities and international centres.